Dissemination of BREASTChoice AIM1-B
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT07396766
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Baseline Questionnaire — BEHAVIORALParticipants will be screened and share demographic information during screening. If eligible and screened in, the interviewer will send the self-administered pre-survey Decision Quality Index (DQI).
- Semi structured Interview — BEHAVIORALParticipants will participate in a semi-structured interview and review of the adapted BREASTChoice tool.
- Post Survey — BEHAVIORALParticipants will take the post-survey to assess breast reconstruction decision quality.
Study Details
This registration covers only Aim 1b, which focuses on testing usability. The study will include 20 participants who are breast cancer patients. Participants will be observed using the tool on their mobile devices, and their experience will be evaluated using a "think-aloud" method to capture their thoughts and reactions. Interviews will include open-ended questions about the content and format of the decision aid, with follow-up prompts to gather feedback on design elements (length, order, graphics), comprehension, ease of use, acceptance, and engagement with the tool. Knowledge will be measured using the Decision Quality Instrument before and after using the tool. Results will be analyzed to develop recommendations for the final version of the tool.
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Jan 2026
- Primary completion
- Jan 20, 2029
- Completion
- Jan 20, 2029
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Breast cancer survivorsBreast cancer survivors.
Primary Outcome Measure
Change in breast reconstruction knowledge [ Time Frame: Up to1 week ]
Central Contacts
- Victoria Triana919-966-4320
- Kathryn A Chetwynd919-966-4320
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of North Carolina | Chapel Hill | North Carolina | 27599 | Clara Lee, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
Related Studies
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama